NASDAQ:ICLR

ICON Public - ICLR Price Target & Analyst Ratings

$212.71

+4.13 (+1.98%)

(As of 03/21/2023 12:10 PM ET)

Add

Compare

Today's Range: $210.19
▼
$214.39
50-Day Range: $207.75
▼
$245.33
52-Week Range: $171.43
▼
$263.62

Volume: 122,884 shs
Average Volume: 517,564 shs
Market Capitalization: $17.38 billion

P/E Ratio: 34.70
Dividend Yield: N/A
Price Target: $266.70

Institutional Ownership

ICON Public Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$266.70
25.38% Upside

High Prediction	$290.00
Average Prediction	$266.70
Low Prediction	$250.00

Type	Current 3/21/22 to 3/21/23	1 Month Ago 2/19/22 to 2/19/23	3 Months Ago 12/21/21 to 12/21/22	1 Year Ago 3/21/21 to 3/21/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$266.70	$264.70	$260.30	$277.11
Predicted Upside	25.38% Upside	22.22% Upside	25.51% Upside	20.17% Upside

Get ICON Public Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

ICLR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ICON Public Stock vs. The Competition

Type	ICON Public	Medical Companies	S&P 500
Consensus Rating Score	2.82	2.64	2.47
Consensus Rating	Moderate Buy	Buy	Hold
Predicted Upside	25.97% Upside	1,922.99% Upside	20.93% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/24/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$265.00 ➝ $285.00	+27.73%
1/20/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$255.00 ➝ $262.00	+13.77%
1/13/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$215.00 ➝ $260.00	+16.77%
11/10/2022	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$272.00 ➝ $250.00	+21.22%
11/9/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$265.00 ➝ $260.00	+33.29%
10/18/2022	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$295.00 ➝ $280.00	+52.96%

9/7/2022	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$270.00	+29.34%
8/24/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$260.00	+14.37%
7/28/2022	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Kreger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
7/8/2022	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$315.00 ➝ $290.00	+30.10%
4/25/2022	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$280.00 ➝ $250.00	+6.86%
9/27/2021	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$230.00 ➝ $320.00	+13.06%
9/14/2021	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$276.00 ➝ $302.00	+17.61%
2/26/2021	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$280.00	+51.81%
4/27/2020	SunTrust Banks Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sandy Draper Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold	$131.00 ➝ $157.00	+5.36%

(Data available from 3/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

ICLR Price Target - Frequently Asked Questions

What is ICON Public's consensus rating and price target?: According to the issued ratings of 11 analysts in the last year, the consensus rating for ICON Public stock is Moderate Buy based on the current 2 hold ratings and 9 buy ratings for ICLR. The average twelve-month price prediction for ICON Public is $266.70 with a high price target of $290.00 and a low price target of $250.00. Learn more on ICLR's analyst rating history.
Do Wall Street analysts like ICON Public more than its competitors?: Analysts like ICON Public more than other Medical companies. The consensus rating for ICON Public is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how ICLR compares to other companies.
Is ICON Public being upgraded by Wall Street analysts?: Over the previous 90 days, ICON Public's stock had 1 upgrade by analysts.

Does ICON Public's stock price have much upside?: According to analysts, ICON Public's stock has a predicted upside of 23.20% based on their 12-month price targets.
What analysts cover ICON Public?: ICON Public has been rated by Barclays, Guggenheim, and Robert W. Baird in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NASDAQ:ICLR) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial